Cargando…
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
BACKGROUND: The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the dose-survival relationship to optimize dose...
Autores principales: | Su, Ting-Shi, Liu, Qiu-Hua, Zhu, Xiao-Fei, Liang, Ping, Liang, Shi-Xiong, Lai, Lin, Zhou, Ying, Huang, Yong, Cheng, Tao, Li, Le-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058965/ https://www.ncbi.nlm.nih.gov/pubmed/33882972 http://dx.doi.org/10.1186/s13014-021-01778-6 |
Ejemplares similares
-
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
por: Li, Jian-Xu, et al.
Publicado: (2022) -
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
por: Liang, Ping, et al.
Publicado: (2016) -
Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: Yao, Erhua, et al.
Publicado: (2018) -
Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis
por: Su, Ting-Shi, et al.
Publicado: (2020) -
Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy
por: Su, Ting-Shi, et al.
Publicado: (2019)